{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T14:11:05Z","timestamp":1724854265635},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["No.2023JJ30003","No.2023JJ30748"],"award-info":[{"award-number":["No.2023JJ30003","No.2023JJ30748"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Hunan Provincial Health Commission","award":["No.C202307027337","No.D202307028349"],"award-info":[{"award-number":["No.C202307027337","No.D202307028349"]}]},{"name":"Natural Science Foundation of Changsha","award":["No. kq2208494"],"award-info":[{"award-number":["No. kq2208494"]}]},{"name":"Science and Technology Program of Changsha","award":["No.kh2302036"],"award-info":[{"award-number":["No.kh2302036"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-024-03619-y","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T07:04:16Z","timestamp":1724137456000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal imaging to distinguish microvascular and morphological changes in retinal vein occlusion after intravitreal ranibizumab with or without triamcinolone acetonide injection"],"prefix":"10.1186","volume":"24","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingling","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"6","key":"3619_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.survophthal.2018.04.005","volume":"63","author":"M Khayat","year":"2018","unstructured":"Khayat M, Williams M, Lois N. Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion. Surv Ophthalmol. 2018;63(6):816\u201350.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"3619_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/2013.jamaophthalmol.228","volume":"131","author":"H Noma","year":"2013","unstructured":"Noma H, Mimura T, Eguchi S. Association of inflammatory factors with macular edema in branch retinal vein occlusion. JAMA Ophthalmol. 2013;131(2):160\u20135.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3619_CR3","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1111\/aos.13152","volume":"95","author":"S Rezar-Dreindl","year":"2017","unstructured":"Rezar-Dreindl S, Eibenberger K, Pollreisz A, B\u00fchl W, Georgopoulos M, Krall C, et al. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion. Acta Ophthalmol. 2017;95(2):e119\u201327.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"3619_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/0300060515617386","volume":"44","author":"S Zhang","year":"2016","unstructured":"Zhang S, An N, Ha W, Zhang S, Hu X, Ma A, et al. Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion. J Int Med Res. 2016;44(3):685\u201397.","journal-title":"J Int Med Res"},{"issue":"1","key":"3619_CR5","first-page":"69","volume":"16","author":"N Floman","year":"1977","unstructured":"Floman N, Zor U. Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production. Invest Ophthalmol Vis Sci. 1977;16(1):69\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3619_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1001\/archopht.1985.01050050100026","volume":"103","author":"T Ishibashi","year":"1985","unstructured":"Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol. 1985;103(5):708\u201311.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"3619_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0014-2999(01)01192-X","volume":"425","author":"N Bandi","year":"2001","unstructured":"Bandi N, Kompella UB. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol. 2001;425(2):109\u201316.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"3619_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000126692","volume":"59","author":"PY Sze","year":"1994","unstructured":"Sze PY, Iqbal Z. Glucocorticoid action on depolarization-dependent calcium influx in brain synaptosomes. Neuroendocrinology. 1994;59(5):457\u201365.","journal-title":"Neuroendocrinology"},{"issue":"8","key":"3619_CR9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/archopht.1992.01080200135041","volume":"110","author":"CA Wilson","year":"1992","unstructured":"Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E. Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol. 1992;110(8):1155\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3619_CR10","first-page":"3125","volume":"43","author":"PL Penfold","year":"2002","unstructured":"Penfold PL, Wen L, Madigan MC, King NJ, Provis JM. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci. 2002;43(9):3125\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3619_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","volume":"58","author":"W Kiddee","year":"2013","unstructured":"Kiddee W, Trope GE, Sheng L, Beltran-Agullo L, Smith M, Strungaru MH, et al. Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol. 2013;58(4):291\u2013310.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"3619_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1517\/14740338.2012.635141","volume":"11","author":"D Veritti","year":"2012","unstructured":"Veritti D, Di Giulio A, Sarao V, Lanzetta P. Drug safety evaluation of intravitreal triamcinolone acetonide. Expert Opin Drug Saf. 2012;11(2):331\u201340.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"3619_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","volume":"101","author":"T Hida","year":"1986","unstructured":"Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 1986;101(2):190\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3619_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-017-0537-6","volume":"62","author":"H Terasaki","year":"2018","unstructured":"Terasaki H, Ogura Y, Kitano S, Sakamoto T, Murata T, Hirakata A, et al. Management of diabetic macular edema in Japan: a review and expert opinion. Jpn J Ophthalmol. 2018;62(1):1\u201323.","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"3619_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3109\/02713683.2014.885533","volume":"39","author":"C Fan","year":"2014","unstructured":"Fan C, Wang Y, Ji Q, Zhao B, Xie J. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion. Curr Eye Res. 2014;39(9):938\u201343.","journal-title":"Curr Eye Res"},{"key":"3619_CR16","doi-asserted-by":"crossref","unstructured":"Hirano Y, Suzuki N, Tomiyasu T, Kurobe R, Yasuda Y, Esaki Y et al. Multimodal Imaging of Microvascular Abnormalities in retinal vein occlusion. J Clin Med. 2021, 10(3).","DOI":"10.3390\/jcm10030405"},{"issue":"12","key":"3619_CR17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3928\/23258160-20211118-01","volume":"52","author":"MV Cicinelli","year":"2021","unstructured":"Cicinelli MV, Sadiq SA, Mishra S, Jampol LM, Mirza RG. Multimodal Imaging Characterization of Arteriolosclerotic Plaques in retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina. 2021;52(12):650\u20137.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"3619_CR18","doi-asserted-by":"publisher","first-page":"Np50","DOI":"10.1177\/1120672121991389","volume":"32","author":"L Remol\u00ed Sargues","year":"2022","unstructured":"Remol\u00ed Sargues L, Montero Hern\u00e1ndez J, Navarro Palop C, Monferrer Adsuara C, Castro Navarro V, Cervera Taulet E. Multimodal imaging of two cases of retinal vein occlusion secondary to Waldenstrom macroglobulinemia. Eur J Ophthalmol. 2022;32(3):Np50\u20135.","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"3619_CR19","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/IAE.0000000000001404","volume":"37","author":"Z Sun","year":"2017","unstructured":"Sun Z, Zhou H, Lin B, Jiao X, Luo Y, Zhang F, et al. Efficacy and Safety of Intravitreal Conbercept Injections in Macular Edema Secondary to retinal vein occlusion. Retina. 2017;37(9):1723\u201330.","journal-title":"Retina"},{"issue":"6","key":"3619_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1159\/000507712","volume":"243","author":"O Dikmetas","year":"2020","unstructured":"Dikmetas O, Kuehlewein L, Gelisken F. Rebound Phenomenon after Intravitreal Injection of Triamcinolone Acetonide for Macular Edema. Ophthalmologica. 2020;243(6):420\u20135.","journal-title":"Ophthalmologica"},{"issue":"9","key":"3619_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","volume":"127","author":"MS Ip","year":"2009","unstructured":"Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs corticosteroid for retinal vein occlusion (SCORE) study report 5. Arch Ophthalmol. 2009;127(9):1101\u201314.","journal-title":"Arch Ophthalmol"},{"issue":"13","key":"3619_CR22","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1167\/iovs-16-20648","volume":"57","author":"N Suzuki","year":"2016","unstructured":"Suzuki N, Hirano Y, Tomiyasu T, Esaki Y, Uemura A, Yasukawa T, et al. Retinal hemodynamics seen on Optical Coherence Tomography Angiography before and after treatment of retinal vein occlusion. Invest Ophthalmol Vis Sci. 2016;57(13):5681\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3619_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ophtha.2012.09.032","volume":"120","author":"PA Campochiaro","year":"2013","unstructured":"Campochiaro PA, Bhisitkul RB, Shapiro H, Rubio RG. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology. 2013;120(4):795\u2013802.","journal-title":"Ophthalmology"},{"issue":"4","key":"3619_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(14)70001-7","volume":"117","author":"SS Hayreh","year":"1994","unstructured":"Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117(4):429\u201341.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3619_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/bjo.2009.160986","volume":"94","author":"M Shimura","year":"2010","unstructured":"Shimura M, Yasuda K. Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease. Br J Ophthalmol. 2010;94(3):381\u20133.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3619_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000235726","volume":"224","author":"ZL Huang","year":"2010","unstructured":"Huang ZL, Lin KH, Lee YC, Sheu MM, Tsai RK. Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome. Ophthalmologica. 2010;224(2):86\u20139.","journal-title":"Ophthalmologica"},{"issue":"3","key":"3619_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ophtha.2015.10.030","volume":"123","author":"TA Mir","year":"2016","unstructured":"Mir TA, Kherani S, Hafiz G, Scott AW, Zimmer-Galler I, Wenick AS, et al. Changes in Retinal Nonperfusion Associated with suppression of vascular endothelial growth factor in retinal vein occlusion. Ophthalmology. 2016;123(3):625\u2013e341.","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"3619_CR28","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1097\/IAE.0000000000001289","volume":"36","author":"V Man\u00e9","year":"2016","unstructured":"Man\u00e9 V, Dupas B, Gaudric A, Bonnin S, Pedinielli A, Bousquet E, et al. Correlation between Cystoid spaces in Chronic Diabetic Macular Edema and Capillary Nonperfusion detected by Optical Coherence Tomography Angiography. Retina. 2016;36(Suppl 1):S102\u201310.","journal-title":"Retina"},{"issue":"7","key":"3619_CR29","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1167\/iovs.17-23437","volume":"59","author":"A Winegarner","year":"2018","unstructured":"Winegarner A, Wakabayashi T, Fukushima Y, Sato T, Hara-Ueno C, Busch C, et al. Changes in Retinal Microvasculature and Visual Acuity after Antivascular endothelial growth factor therapy in retinal vein occlusion. Invest Ophthalmol Vis Sci. 2018;59(7):2708\u201316.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3619_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3928\/15428877-20090430-17","volume":"40","author":"EJ Sabet-Peyman","year":"2009","unstructured":"Sabet-Peyman EJ, Heussen FM, Thorne JE, Casparis H, Patel SJ, Do DV. Progression of macular ischemia following intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2009;40(3):316\u20138.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"7","key":"3619_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1755-3768.2009.01535.x","volume":"88","author":"AM Mansour","year":"2010","unstructured":"Mansour AM, Bynoe LA, Welch JC, Pesavento R, Mahendradas P, Ziemssen F, et al. Retinal vascular events after intravitreal bevacizumab. Acta Ophthalmol. 2010;88(7):730\u20135.","journal-title":"Acta Ophthalmol"},{"key":"3619_CR32","doi-asserted-by":"crossref","unstructured":"Chatziralli I, Dimitriou E, Lambadiari V, Kazantzis D, Kapsis P, Theodossiadis G et al. The impact of Laboratory findings and Optical Coherence Tomography biomarkers on response to Intravitreal Anti-VEGF Treatment in patients with Diabetic Macular Edema. Semin Ophthalmol. 2022:1\u20138.","DOI":"10.1080\/08820538.2022.2069470"},{"issue":"8","key":"3619_CR33","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1097\/IAE.0000000000001749","volume":"38","author":"R Ghashut","year":"2018","unstructured":"Ghashut R, Muraoka Y, Ooto S, Iida Y, Miwa Y, Suzuma K, et al. Evaluation of Macular Ischemia in eyes with central retinal vein occlusion: an Optical Coherence Tomography Angiography Study. Retina. 2018;38(8):1571\u201380.","journal-title":"Retina"},{"issue":"6","key":"3619_CR34","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/bjophthalmol-2016-308726","volume":"101","author":"P Iacono","year":"2017","unstructured":"Iacono P, Parodi MB, Scaramuzzi M, Bandello F. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant. Br J Ophthalmol. 2017;101(6):791\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"3619_CR35","first-page":"915","volume":"41","author":"DD Sevgi","year":"2021","unstructured":"Sevgi DD, Yee PS, Srivastava SK, Le TK, Abraham JR, Reese J, et al. Longitudinal Ellipsoid Zone dynamics after Macular Hole Repair in the Discover Study. Structure-Function Assess Retina. 2021;41(5):915\u201320.","journal-title":"Structure-Function Assess Retina"},{"issue":"2","key":"3619_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/IAE.0000000000003306","volume":"42","author":"TS Tuifua","year":"2022","unstructured":"Tuifua TS, Abraham JR, Srivastava SK, Kaiser PK, Reese J, Ehlers JP. Longitudinal ellipsoid zone and Outer Retinal Integrity Dynamics after Epiretinal membrane surgery. Retina. 2022;42(2):265\u201373.","journal-title":"Retina"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03619-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T07:04:53Z","timestamp":1724137493000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03619-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3619"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03619-y","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"20 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a retrospective study conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Second Xiangya Hospital, which waived the written informed consent because of the study\u2019s retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}